Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.52 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.52 |
| ▸ | F13A1 | P00488 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
| ▸ | ESRRB | O95718 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.49 |
| ▸ | RELA | Q04206 | 2/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Hydroxyhydrocinnamic Acid Methyl Ester SCHEMBL30611554 | 0.98 | HDAC2 (0.51) | HDAC2HDAC8MEN1KMT2AKDM4E | |
| 4-Hydroxyhydrocinnamic Acid Methyl Ester SCHEMBL8767620 | 0.93 | FFAR1 (0.54) | HDAC2HDAC8MEN1KMT2AESR1 | |
| SCHEMBL22922181 | 0.92 | CYP4F2 (0.59) | KMT2ACYP4F2CYP4A11F2RL1ADRB2 | |
| SCHEMBL3469156 | 0.91 | MAPT (0.50) | HDAC2HDAC8MEN1KMT2AKDM4E | |
| SCHEMBL8767622 | 0.90 | KMT2A (0.66) | HDAC2HDAC8MEN1KMT2AF2RL1 | |
| SCHEMBL1863579 | 0.89 | CALM1 (0.55) | KDM4ECYP4F2CYP4A11F13A1ESR1 | |
| 4-Hydroxyhydrocinnamic Acid Methyl Ester SCHEMBL8402039 | 0.88 | FFAR1 (0.61) | KDM4EESRRBALDH1A1LMNATDP1 | |
| SCHEMBL11509970 | 0.88 | CYP4F2 (0.50) | HDAC2HDAC8MEN1KMT2AKDM4E | |
| SCHEMBL2158877 | 0.87 | CALM1 (0.53) | KDM4EESR1ALDH1A1LMNATP53 | |
| SCHEMBL11720060 | 0.86 | CYP4F2 (0.50) | KMT2AKDM4ECYP4F2CYP4A11F2RL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747215-A1 | PYRAZOLE DERIVATIVES AS DUAL FUNCTION UREASE AND NITRIFICATION INHIBITOR | Sabic Agri-Nutrients Company (SA) | 2026-05-27 | — | — | EP | claimed |
| WO-2026099762-A1 | AMINODITHIOCARBAMATE DERIVATIVES AS DUAL FUNCTION UREASE AND NITRIFICATION INHIBITOR | SABIC Agri-Nutrients Company (SA) | 2026-05-15 | — | — | WO | claimed |
| CN-122029140-A | Pyrazole derivatives as dual function urease and nitrification inhibitors | 沙特基础工业公司农业营养素 | 2026-05-12 | — | — | CN | claimed |
| EP-4660175-A1 | NITRIFICATION INHIBITOR FOR FERTILIZER APPLICATION | Sabic Agri-Nutrients Company (SA) | 2025-12-10 | — | — | EP | claimed |
| WO-2025099631-A1 | UREASE INHIBITOR FOR FERTILIZER APPLICATION | SABIC Agri-Nutrients Company (SA) | 2025-05-15 | — | — | WO | claimed |
| CN-119954554-A | Novel synergistic nitrogen fertilizer with inhibitor wrapped by organic material and preparation process thereof | 中国科学院南京土壤研究所 | 2025-05-09 | — | — | CN | claimed |
| CN-119855797-A | Triazolyl carbinols as nitrification inhibitors for fertilizer applications | 沙特基础工业公司农业营养素 | 2025-04-18 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| WO-2025016960-A1 | PYRAZOLE DERIVATIVES AS DUAL FUNCTION UREASE AND NITRIFICATION INHIBITOR | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-01-23 | — | — | WO | claimed |
| CN-118901365-A | Method for improving nitrogen fertilizer utilization rate based on synergistic effect of humic acid and biological nitrification inhibitor | 中国科学院南京土壤研究所 | 2024-11-08 | — | — | CN | claimed |
| US-7183281-B2 | Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists | ELAN PHARMACEUTICALS, INC. (US) | 2007-02-27 | — | — | US | claimed |
| US-7074783-B2 | Sulfonylbenzodiazepinone acetamides as bradykinin antagonists | ELAN PHARMACEUTICALS, INC. (US) | 2006-07-11 | — | — | US | claimed |
| EP-1549622-A1 | SULFONYLBENZODIAZEPINONE ACETAMIDES AS BRADYKININ ANTAGONISTS | Elian Pharmaceuticals Inc. (US) | 2005-07-06 | — | — | EP | claimed |
| EP-1501807-A1 | SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS | Elan Pharmaceuticals, Inc. (US) | 2005-02-02 | — | — | EP | claimed |
| CN-1181055-C | Alanine class compound, its preparing method and use | 中国科学院上海药物研究所 | 2004-12-22 | — | — | CN | claimed |
| US-20040147520-A1 | Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists | ELAN PHARMACEUTICALS, INC. | 2004-07-29 | — | — | US | claimed |
| US-20040138208-A1 | Sulfonylbenzodiazepinone acetamides as bradykinin antagonists | ELAN PHARMACEUTICALS, INC. | 2004-07-15 | — | — | US | claimed |
| WO-2004033436-A1 | SULFONYLBENZODIAZEPINONE ACETAMIDES AS BRADYKININ ANTAGONISTS | ELAN PHARMACEUTICALS INC (US) | 2004-04-22 | — | — | WO | claimed |
| WO-2003093245-A1 | SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS | ELAN PHARMACEUTICALS, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| CN-1431197-A | Alanine class compound, its preparing method and use | SHANGHAI INST OF MEDICATION CH (CN) | 2003-07-23 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147520-A1 | Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists | BDKRB2, BDKRB1, PDXK | HDAC2 2184/4885HDAC8 1982/4885MEN1 1916/4885 |
| US-20040138208-A1 | Sulfonylbenzodiazepinone acetamides as bradykinin antagonists | BDKRB1, BDKRB2, HRH2 | HDAC2 894/4885HDAC8 1433/4885MEN1 1958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.